IRIS
MATALUNI, GIORGIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.836
EU - Europa 989
AS - Asia 604
SA - Sud America 12
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
AF - Africa 1
Totale 9.449
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.829
IT - Italia 402
SG - Singapore 307
KR - Corea 177
IE - Irlanda 151
DE - Germania 94
UA - Ucraina 89
RU - Federazione Russa 81
CN - Cina 78
GB - Regno Unito 60
FR - Francia 23
FI - Finlandia 21
SE - Svezia 19
NL - Olanda 14
IN - India 13
BR - Brasile 10
RO - Romania 10
CA - Canada 7
CH - Svizzera 6
TR - Turchia 5
CZ - Repubblica Ceca 4
JP - Giappone 4
KG - Kirghizistan 4
AU - Australia 3
HK - Hong Kong 3
IQ - Iraq 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AT - Austria 2
BE - Belgio 2
CL - Cile 2
DK - Danimarca 2
ES - Italia 2
IR - Iran 2
PL - Polonia 2
SK - Slovacchia (Repubblica Slovacca) 2
UZ - Uzbekistan 2
VN - Vietnam 2
BD - Bangladesh 1
EU - Europa 1
GR - Grecia 1
HR - Croazia 1
ID - Indonesia 1
JO - Giordania 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
ZA - Sudafrica 1
Totale 9.449
Salva come PNG Salva come JPEG
Città #
Wilmington 2.268
Houston 1.987
Woodbridge 1.801
Chandler 275
Singapore 262
Fairfield 176
Dublin 142
New York 135
Ann Arbor 112
Medford 86
Ashburn 80
Santa Clara 74
Cambridge 72
Seattle 67
Rome 66
Dearborn 54
Jacksonville 48
Lawrence 41
Beijing 39
Milan 29
Roebling 23
Moscow 21
Piove di Sacco 18
San Diego 17
Palo Alto 14
Seoul 12
San Jose 11
Turin 10
Naples 9
Creede 8
Florence 8
Redwood City 8
Bologna 7
London 7
Verona 7
Lodi 6
Mülheim 6
Norwalk 6
Nuremberg 6
Council Bluffs 5
Istanbul 5
Kilburn 5
Menlo Park 5
Munich 5
Bergamo 4
Brno 4
Engelhard 4
Inverigo 4
Jinan 4
Kunming 4
Lappeenranta 4
Lausanne 4
Mountain View 4
Palermo 4
Paris 4
San Francisco 4
Schio 4
Vicenza 4
Viterbo 4
Andover 3
Boardman 3
Cercenasco 3
Chengdu 3
Guidonia 3
Helsinki 3
Hounslow 3
Karbala 3
Nanjing 3
Salt Lake City 3
São Paulo 3
Abbiategrasso 2
Ahmedabad 2
Amsterdam 2
Atlanta 2
Bengaluru 2
Berlin 2
Billings 2
Bogliasco 2
Bolzano Vicentino 2
Brussels 2
Burnaby 2
Capaccio 2
Carugate 2
Castelfidardo 2
Catania 2
Chiswick 2
Delhi 2
Desio 2
Edmond 2
Essen 2
Falls Church 2
Gunzenhausen 2
Hefei 2
Ho Chi Minh City 2
Hong Kong 2
La Spezia 2
La Veta 2
Lissone 2
Littleton 2
Los Angeles 2
Totale 8.196
Salva come PNG Salva come JPEG
Nome #
Anti-sulfatide/galactocerebroside antibodies in immunoglobulin M paraproteinemic neuropathies 430
International Guillain-Barré Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barré syndrome 418
Central and peripheral nervous system involvement as a manifestation of graft versus host disease after liver transplantation: case report 405
IgM MGUS and Waldenstrom-associated anti-MAG neuropathies display similar response to rituximab therapy 400
EPIDEMIOLOGY AND POTENTIAL PROGNOSTIC FACTORS IN GUILLAIN-BARRE SYNDROME: TEN-YEAR EXPERIENCE OF "POLICLINICO TOR VERGATA" 397
Acute disseminated encephalomyelitis following Campylobacter jejuni gastroenteritis: Case report and review of the literature 395
Bickerstaff encephalitis with anti gm1-antibodies relapsing as guillain-barre syndrome: a case report 383
A multicentric cohort study on anti-mag antibodies neuropathy: does response to rituximab differ depending on the associated hematological disease? 383
Bickerstaff encephalitis: report of two atypical cases with negative anti GQ1B antibodies 371
Diabetic peripheral neuropathic pain is a stronger predictor of depression than other diabetic complications and comorbidities 364
Meningomyeloradiculitis mimicking recurrent bilateral neuralgic amyotrophy. 339
Autonomic nervous system involvement in patients with chronic dysimmune neuropathies 337
A multicentric cohort study on anti-mag antibodies neuropathy: does response to rituximab differ depending on the associated hematological disease? 332
High dose intravenous immunoglobulin is effective in painful diabetic polyneuropathy resistant to conventional treatments: results of a double blind, randomized, placebo-controlled, multicenter trial 322
Motor unit number estimation in 30 patients with chronic dysimmune neuropathies 318
Neuroretinal dysfunction is associated with early peripheral motor unit loss in type 1 diabetes 289
Platelet-derived growth factor predicts prolonged relapse-free period in multiple sclerosis 280
Miscarriage induces reactivation of inflammation in relapsing-remitting multiple sclerosis 276
Regional variation of Guillain-Barré syndrome 263
Atypical CIDP: diagnostic criteria, progression and treatment response. Data from the Italian CIDP Database 261
PREVALENCE OF ANTI-NEUROFASCIN-155, ANTI-CONTACTIN-1 AND ANTI-CONTACTIN-ASSOCIATED PROTEIN-1 ANTIBODIES IN CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY: A SEROLOGICAL MULTICENTER STUDY IN ITALY 223
Neuroretinal Dysfunction Is Associated with Early Peripheral Motor Unit Loss in Type 1 Diabetes Mellitus 222
Association between Early Neuroretinal Dysfunction and Peripheral Motor Unit Loss in Patients with Type 1 Diabetes Mellitus 214
PREVALENCE OF ANTI-NEUROFASCIN-155, ANTI-CONTACTIN-1 AND CONTACTIN-ASSOCIATED PROTEIN 1 ANTIBODIES IN CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY: A SEROLOGICAL MULTICENTER STUDY IN ITALY 212
Treatment with Dimethyl Fumarate Enhances Cholinergic Transmission in Multiple Sclerosis 155
Validity of the Italian multiple sclerosis neuropsychological screening questionnaire 132
Current treatment practice of Guillain-Barré syndrome 120
Adherence to social distancing and use of personal protective equipment and the risk of SARS-CoV-2 infection in a cohort of patients with multiple sclerosis 120
Chronic inflammatory demyelinating polyradiculoneuropathy: can a diagnosis be made in patients not fulfilling electrodiagnostic criteria? 109
Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype 107
Risk factors for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): antecedent events, lifestyle and dietary habits. Data from the Italian CIDP Database 101
Correction to: Validity of the Italian multiple sclerosis neuropsychological screening questionnaire 64
Assessment of macular function by multifocal electroretinogram in patients with multiple sclerosis treated with fingolimod 64
Complex Rearrangement of the Entire Retinal Posterior Pole in Patients with Relapsing Remitting Multiple Sclerosis 62
The neurophysiological lesson from the Italian CIDP database 54
Patient's point of view on the use of telemedicine in multiple sclerosis: a web-based survey 53
Abortion induces reactivation of inflammation in relapsing-remitting multiple sclerosis 46
Safety of Natalizumab infusion in multiple sclerosis patients during active SARS-CoV-2 infection 44
Prolonged distal motor latency of median nerve does not improve diagnostic accuracy for CIDP 40
Frequency of diabetes and other comorbidities in chronic inflammatory demyelinating polyradiculoneuropathy and their impact on clinical presentation and response to therapy 39
Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis 36
Cladribine vs other drugs in MS: Merging randomized trial with real-life data 33
Assessment of Macular Function by Multifocal Electroretinogram in Patients with Multiple Sclerosis Treated with Fingolimod 32
Influence of Previous Disease-Modifying Drug Exposure on T-Lymphocyte Dynamic in Patients With Multiple Sclerosis Treated With Ocrelizumab 32
Anti-HBs titers are not decreased after treatment with oral Cladribine in patients with Multiple Sclerosis vaccinated against Hepatitis B virus 31
Response to Dr. Wee 29
Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders 29
Risk of disease relapse, safety and tolerability of SARS-CoV-2 vaccination in patients with chronic inflammatory neuropathies 28
First therapy choice in newly diagnosed Multiple Sclerosis patients: A multicenter Italian study 28
Exit strategies for "needle fatigue" in multiple sclerosis: a propensity score-matched comparison study 27
Multifocal Electroretinogram Photopic Negative Response: A Reliable Paradigm to Detect Localized Retinal Ganglion Cells' Impairment in Retrobulbar Optic Neuritis Due to Multiple Sclerosis as a Model of Retinal Neurodegeneration 27
Unclassified clinical presentations of chronic inflammatory demyelinating polyradiculoneuropathy 24
Assessment of diagnostic criteria for multifocal motor neuropathy in patients included in the Italian database 23
Electrodiagnosis of Guillain-Barre syndrome in the International GBS Outcome Study: Differences in methods and reference values 22
COVID-19 vaccine hesitancy among Italian people with multiple sclerosis 21
Impact of environmental factors and physical activity on disability and quality of life in CIDP 20
MRI activity and extended interval of Natalizumab dosing regimen: a multicentre Italian study 16
Impact of 2021 European Academy of Neurology/Peripheral Nerve Society diagnostic criteria on diagnosis and therapy of chronic inflammatory demyelinating polyradiculoneuropathy variants 12
High-Dose Intravenous Immunoglobulin Is Effective in Painful Diabetic Polyneuropathy Resistant to Conventional Treatments. Results of a Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial 12
Topographical Correlation between Structural and Functional Impairment of the Macular Inner Retinal Layers in Multiple Sclerosis Eyes with a History of Optic Neuropathy 11
Maternal and fetal outcomes in an Italian multicentric cohort of women with multiple sclerosis exposed to dimethyl fumarate during pregnancy 9
null 3
Totale 9.649
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.218
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.218
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.467 0 0 0 0 191 226 172 175 220 170 153 160
2020/20211.575 151 151 150 171 231 197 204 148 52 36 62 22
2021/2022433 28 35 13 38 24 42 13 19 32 38 28 123
2022/2023898 53 58 113 136 65 162 93 43 81 5 65 24
2023/2024387 65 12 27 22 31 62 27 11 23 22 3 82
2024/2025681 46 308 160 108 59 0 0 0 0 0 0 0
Totale 9.649